Orthofix Announces Milestone − More Than 60,000 M6-C Artificial Cervical Discs Implanted Worldwide

October 16, 2022

Did you know that Orthofix M6-C discs have been implanted in more than 60,000 patients around the world? The M6-C artificial disc implant is a next-generation artificial disc designed to mimic the natural motion of a native disc. It was developed specifically with the intention of replacing an intervertebral disc damaged by cervical disc degeneration. The M6-C disc is indicated as an alternative to cervical fusion. The disc was first approved for distribution under the CE Mark in the European Union and other international geographies. The M6-C disc also received U.S. Food and Drug Administration (FDA) approval in 2019.

“The M6-C artificial cervical disc is continuing to establish a market-leading position globally with more than 60,000 devices implanted worldwide,” said Orthofix President of Global Spine Kevin Kenny. “We are pleased to see the continued adoption of this state-of-the-art technology as our international success translates into the U.S. market.”

The M6-C disc is produced from an artificial visco-elastic nucleus and fiber annulus. Like a natural vertebral disc, this unique design allows for shock absorption at the implanted level and provides a controlled range of motion as the spine bends and translates in multiple planes. The M6-C disc is the only such device available in the U.S. with these features.

Read the complete press release from Orthofix here.